{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-051900","form_type":"8-K","ticker":"AMRX","cik":"0001723128","company_name":"Amneal Pharmaceuticals, Inc.","filed_at":"2026-08-03T20:28:16+00:00","discovered_at":"2026-08-03T20:31:00.632688+00:00","generated_at":"2026-08-03T20:31:23.473533+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Amneal reprices $2.084B term loan, cuts interest margin by 50 bps, saving ~$12M annually","bullets":["Reduced interest rate margin by 50 bps to 1.50% (base rate) and 2.50% (SOFR) on $2.084B term loans.","Converted $2.039B existing term loans on cashless basis; added $45.2M new term loan to repay non-converted loans.","Maturity unchanged at August 1, 2032; no prepayment premium for repricing after February 3, 2027.","Estimated annualized cash interest savings of approximately $12 million based on outstanding borrowings."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-051900","json":"https://secwatch.observer/filing/0001628280-26-051900.json","markdown":"https://secwatch.observer/filing/0001628280-26-051900.md","text":"https://secwatch.observer/filing/0001628280-26-051900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026051900/0001628280-26-051900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026051900/amrx-20260803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T20:31:23.473533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}